Ownership and insider activity for Agilent Technologies, Inc. (A): recent transactions by executives and directors. Track how corporate insiders are trading the stock.
Agilent Technologies, Inc. delivers specialized, application-focused technologies and services to the global life sciences, diagnostics, and applied chemistry industries. Its Life Sciences and Applied Markets segment provides a comprehensive portfolio of analytical instrumentation. This includes liquid chromatography (LC) and gas chromatography (GC) systems, often integrated with mass spectrometry (MS) for advanced analysis (LC-MS, GC-MS).
Price
| Price | $174.87 (closing price, October 30, 2026) |
| Market Cap | $49.3B |
| Exchange | NYSE |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-09-08 | Boehnlein Glenn S | A-Award | 817 | $120K |
| 2026-09-04 | Boehnlein Glenn S | |||
| 2026-09-04 | Boehnlein Glenn S | |||
| 2026-09-04 | Dolsten Mikael | S-Sale | 634 | $96K |
| 2026-06-26 | KIRKWOOD JONAH PREVOST | F-InKind | 30 | $4K |
| 2026-06-02 | Downs Timothy Charles | |||
| 2026-06-03 | MCDONNELL PADRAIG | F-InKind | 418 | $57K |
| 2026-05-29 | Dolsten Mikael | S-Sale | 1,600 | $217K |
| 2026-05-19 | Buckner Michael Steven | A-Award | 8,872 | |
| 2026-05-08 | MAY SIMON | F-InKind | 368 | $43K |
Balance Sheet (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2.29B | $2.68B | $2.25B | $1.38B | $1.44B | $1.48B | $1.05B | $1.59B | $1.33B | $1.79B |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 | $91.0M | 0 | 0 | 0 | 0 |
| Receivables | $631.0M | $724.0M | $776.0M | $930.0M | $1.04B | $1.17B | $1.41B | $1.29B | $1.32B | $1.49B |
| Inventory | $533.0M | $575.0M | $638.0M | $679.0M | $720.0M | $830.0M | $1.04B | $1.03B | $991.0M | $1.02B |
| Total Current Assets | $3.63B | $4.17B | $3.85B | $3.19B | $3.42B | $3.80B | $3.78B | $4.19B | $3.96B | $4.59B |
| Property, Plant & Equipment | $639.0M | $757.0M | $822.0M | $850.0M | $845.0M | $945.0M | $1.10B | $1.42B | $1.96B | $2.02B |
| Goodwill | $2.52B | $2.61B | $2.97B | $3.59B | $3.60B | $3.98B | $3.95B | $3.96B | $4.47B | $4.47B |
| Intangible Assets | $408.0M | $361.0M | $491.0M | $1.11B | $831.0M | $981.0M | $821.0M | $475.0M | $547.0M | $445.0M |
| Total Assets | $7.79B | $8.43B | $8.54B | $9.45B | $9.63B | $10.71B | $10.53B | $10.76B | $11.85B | $12.73B |
| Accounts Payable | $257.0M | $305.0M | $340.0M | $354.0M | $354.0M | $446.0M | $580.0M | $418.0M | $540.0M | $570.0M |
| Short-term Debt | 0 | $210.0M | 0 | $616.0M | $75.0M | 0 | $36.0M | 0 | $45.0M | $304.0M |
| Total Current Liabilities | $945.0M | $1.26B | $1.17B | $2.08B | $1.47B | $1.71B | $1.86B | $1.60B | $1.90B | $2.35B |
| Long-term Debt | $1.90B | $1.80B | $1.80B | $1.79B | $2.28B | $2.73B | $2.73B | $2.73B | $3.35B | $3.05B |
| Total Liabilities | $3.55B | $3.59B | $3.97B | $4.70B | $4.75B | $5.32B | $5.23B | $4.92B | $5.95B | $5.99B |
| Retained Earnings | $6.09B | -$126.0M | -$336.0M | -$18.0M | $81.0M | $348.0M | $324.0M | $782.0M | $750.0M | $1.39B |
| Total Equity | $4.24B | $4.83B | $4.57B | $4.75B | $4.87B | $5.39B | $5.30B | $5.84B | $5.90B | $6.74B |
| Total Debt | $1.90B | $2.01B | $1.80B | $2.41B | $2.36B | $2.73B | $2.77B | $2.73B | $3.57B | $3.35B |
| Net Debt | -$385.0M | -$667.0M | -$448.0M | $1.02B | $918.0M | $1.15B | $1.72B | $1.15B | $2.25B | $1.56B |
| Working Capital | $2.69B | $2.91B | $2.68B | $1.11B | $1.95B | $2.09B | $1.92B | $2.58B | $2.06B | $2.25B |
Financial Health
| Debt / Equity | 0.54 |
| Current Ratio | 2.05 |
| Piotroski F-Score | 6 |
| Altman Z-Score | 5.45 |
Profitability
| Return on Equity | 20.47% |
| Return on Invested Capital | 11.88% |
| Return on Assets | 10.31% |
| Gross Margin | 53.73% |
| Operating Margin | 22.23% |
| Net Margin | 19.53% |
Related companies: BRKR · TMO · DHR · MTD · WAT · RVTY · QGEN · BIO
Explore sector: Healthcare · Medical - Diagnostics & Research
More sections of A: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method · Companies that pass the Lynch method · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks